Leishmaniasis Treatment Market size was USD 108.5 Million in 2024 and is projected to touch USD 114.5 Million in 2025 to USD 175.7 Million by 2033, exhibiting a CAGR Of 5.0% during the forecast period [2025-2033].

Detailed TOC of Global Leishmaniasis Treatment Market Insights

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type, 2018 VS 2024 VS 2033
1.2.2 Meglumine Antimoniate
1.2.3 Pentamidine
1.2.4 Hydroxyl Amidine Stilbene
1.2.5 Amphotericin B
1.3 Market by Application
1.3.1 Global Leishmaniasis Treatment Market Size Growth Rate by Application, 2018 VS 2024 VS 2033
1.3.2 Visceral Leishmaniasis
1.3.3 Cutaneous Leishmaniasis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leishmaniasis Treatment Market Perspective (2018-2033)
2.2 Global Leishmaniasis Treatment Growth Trends by Region
2.2.1 Leishmaniasis Treatment Market Size by Region: 2018 VS 2024 VS 2033
2.2.2 Leishmaniasis Treatment Historic Market Size by Region (2018-2024)
2.2.3 Leishmaniasis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Leishmaniasis Treatment Market Dynamics
2.3.1 Leishmaniasis Treatment Industry Trends
2.3.2 Leishmaniasis Treatment Market Drivers
2.3.3 Leishmaniasis Treatment Market Challenges
2.3.4 Leishmaniasis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Leishmaniasis Treatment by Players
3.1.1 Global Leishmaniasis Treatment Revenue by Players (2018-2024)
3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Leishmaniasis Treatment, Ranking by Revenue, 2021 VS 2024 VS 2024
3.4 Global Leishmaniasis Treatment Market Concentration Ratio
3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2024
3.5 Global Key Players of Leishmaniasis Treatment Head office and Area Served
3.6 Global Key Players of Leishmaniasis Treatment, Product and Application
3.7 Global Key Players of Leishmaniasis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Leishmaniasis Treatment Breakdown Data by Type
4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2018-2024)
4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2024-2033)
5 Leishmaniasis Treatment Breakdown Data by Application
5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2018-2024)
5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Leishmaniasis Treatment Market Size (2018-2033)
6.2 North America Leishmaniasis Treatment Market Size by Type
6.2.1 North America Leishmaniasis Treatment Market Size by Type (2018-2024)
6.2.2 North America Leishmaniasis Treatment Market Size by Type (2024-2033)
6.2.3 North America Leishmaniasis Treatment Market Share by Type (2018-2033)
6.3 North America Leishmaniasis Treatment Market Size by Application
6.3.1 North America Leishmaniasis Treatment Market Size by Application (2018-2024)
6.3.2 North America Leishmaniasis Treatment Market Size by Application (2024-2033)
6.3.3 North America Leishmaniasis Treatment Market Share by Application (2018-2033)
6.4 North America Leishmaniasis Treatment Market Size by Country
6.4.1 North America Leishmaniasis Treatment Market Size by Country: 2018 VS 2024 VS 2033
6.4.2 North America Leishmaniasis Treatment Market Size by Country (2018-2024)
6.4.3 North America Leishmaniasis Treatment Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Leishmaniasis Treatment Market Size (2018-2033)
7.2 Europe Leishmaniasis Treatment Market Size by Type
7.2.1 Europe Leishmaniasis Treatment Market Size by Type (2018-2024)
7.2.2 Europe Leishmaniasis Treatment Market Size by Type (2024-2033)
7.2.3 Europe Leishmaniasis Treatment Market Share by Type (2018-2033)
7.3 Europe Leishmaniasis Treatment Market Size by Application
7.3.1 Europe Leishmaniasis Treatment Market Size by Application (2018-2024)
7.3.2 Europe Leishmaniasis Treatment Market Size by Application (2024-2033)
7.3.3 Europe Leishmaniasis Treatment Market Share by Application (2018-2033)
7.4 Europe Leishmaniasis Treatment Market Size by Country
7.4.1 Europe Leishmaniasis Treatment Market Size by Country: 2018 VS 2024 VS 2033
7.4.2 Europe Leishmaniasis Treatment Market Size by Country (2018-2024)
7.4.3 Europe Leishmaniasis Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Leishmaniasis Treatment Market Size (2018-2033)
8.2 China Leishmaniasis Treatment Market Size by Type
8.2.1 China Leishmaniasis Treatment Market Size by Type (2018-2024)
8.2.2 China Leishmaniasis Treatment Market Size by Type (2024-2033)
8.2.3 China Leishmaniasis Treatment Market Share by Type (2018-2033)
8.3 China Leishmaniasis Treatment Market Size by Application
8.3.1 China Leishmaniasis Treatment Market Size by Application (2018-2024)
8.3.2 China Leishmaniasis Treatment Market Size by Application (2024-2033)
8.3.3 China Leishmaniasis Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Leishmaniasis Treatment Market Size (2018-2033)
9.2 Asia Leishmaniasis Treatment Market Size by Type
9.2.1 Asia Leishmaniasis Treatment Market Size by Type (2018-2024)
9.2.2 Asia Leishmaniasis Treatment Market Size by Type (2024-2033)
9.2.3 Asia Leishmaniasis Treatment Market Share by Type (2018-2033)
9.3 Asia Leishmaniasis Treatment Market Size by Application
9.3.1 Asia Leishmaniasis Treatment Market Size by Application (2018-2024)
9.3.2 Asia Leishmaniasis Treatment Market Size by Application (2024-2033)
9.3.3 Asia Leishmaniasis Treatment Market Share by Application (2018-2033)
9.4 Asia Leishmaniasis Treatment Market Size by Region
9.4.1 Asia Leishmaniasis Treatment Market Size by Region: 2018 VS 2024 VS 2033
9.4.2 Asia Leishmaniasis Treatment Market Size by Region (2018-2024)
9.4.3 Asia Leishmaniasis Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country: 2018 VS 2024 VS 2033
10.4.2 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Leishmaniasis Treatment Introduction
11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2018-2024)
11.1.5 Merck Recent Developments
11.2 iCo Therapeutics
11.2.1 iCo Therapeutics Company Details
11.2.2 iCo Therapeutics Business Overview
11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2018-2024)
11.2.5 iCo Therapeutics Recent Developments
11.3 AEterna Zentaris
11.3.1 AEterna Zentaris Company Details
11.3.2 AEterna Zentaris Business Overview
11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2018-2024)
11.3.5 AEterna Zentaris Recent Developments
11.4 AEterna Zentaris AG
11.4.1 AEterna Zentaris AG Company Details
11.4.2 AEterna Zentaris AG Business Overview
11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2018-2024)
11.4.5 AEterna Zentaris AG Recent Developments
11.5 Eurofins Advinus
11.5.1 Eurofins Advinus Company Details
11.5.2 Eurofins Advinus Business Overview
11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2018-2024)
11.5.5 Eurofins Advinus Recent Developments
11.6 Pieris Pharmaceuticals
11.6.1 Pieris Pharmaceuticals Company Details
11.6.2 Pieris Pharmaceuticals Business Overview
11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2018-2024)
11.6.5 Pieris Pharmaceuticals Recent Developments
11.7 Dafra Pharma
11.7.1 Dafra Pharma Company Details
11.7.2 Dafra Pharma Business Overview
11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2018-2024)
11.7.5 Dafra Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details